Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...

SEVEN patients, two of whom are critically ill, have been infected with a contaminated gel during NHS procedures. The ...

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...

Clearly, UNC is behind in the NIL game that keeps evolving, and Hubert Davis has apparently received the go-ahead to add to ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

"If you know, you know,"?a phrase commonly used to refer to something that is understood or known by a select group of people. It is a phrase that applies to more than 10,000 people in Donor Network ...

Julian was diagnosed with Cystic Fibrosis when he was two ... in what will be their brand new house. Once the budget is agreed, the build goes to site, and immediately there are uncontrollable ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

In Monday’s sole IPO launch and with the broader market poised to start the week in the red, Goldman Sachs, TD Cowen, Stifel and Guggenheim Securities began the marketing effort to sell 8.8m shares in ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...